Primary experimental recordNegative / threshold

PMC12935919::ACT037550

Myoki

Evidence text

Paper-level observation

Section 3.3 / Figure 4D: 'Myoki significantly enhanced myostatin binding by more than 150% compared to the control, which was observed at concentrations ≥62.5 μM.'

textConfidence: medium

Assay observation

Activity

Other

Subtype

Other

Measure

other

Comparator

Raw observation

more than 150% (percent)

Normalized measurement

>150%

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

myostatin/GDF-8

Assay method

Not reported by source

Sequence

EAEYEHL

Standardization

ready simple

Source publication

The therapeutic potential of Myoki, a novel peptide in muscle atrophy: mechanisms and applications.

Frontiers in Pharmacology · 2026

DOI 10.3389/fphar.2026.1663850 PMC12935919

Parent mention

Related peptide identities

PEPDIA-PLP-000522

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.